Dynacure Alternatives & Competitors
12 companies similar to Dynacure — Dynacure develops new treatments for orphan disorders, focusing on CNM through D...
Companies similar to Dynacure
Dicerna Pharmaceuticals
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...
Santaris Pharma
Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...
Jupiter Neurosciences, Inc.
A clinical-stage drug platform company focused on treating neuroinflammation.
Rival Readout
Competing with Dynacure? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Versantis
Multiorgan support for rare pediatric and acute liver diseases
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Gain Therapeutics
Unfolding the next generation of allosteric small molecule therapies to meet patient needs...
Anchiano Therapeutics
Dedicated to the discovery, development, and commercialization of novel targeted therapies...
Praxis Precision Medicines, Inc.
The era of genetic neuroscience has arrived
Seelos Therapeutics, Inc.
A clinical-stage biopharmaceutical company focused on central nervous system disorders and...
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
About Dynacure
Dynacure is a biotechnology startup that specializes in developing new treatments for rare orphan disorders, with a primary focus on Centronuclear Myopathies (CNM) through its Dyn101 program. This initiative aims to address the severe effects of CNM, particularly on young individuals, by altering the expression of the...
Development and execution of RNA-targeted therapies for oncology
Patients with cancer and healthcare professionals
Rare Disease Drug Development, Orphan Disorders, Clinical-stage Drug Development, Antisense Medicine, RNA-targeted Drug Discovery, Dynamin 2 Protein Modulation, Centronuclear Myopathies (CNM), Ionis Pharmaceuticals Partnership, Investigational Medicine Development, Clinical Trial Advancement, Biopharmaceutical Research, Dyn101 Program, Orphan Disease Therapeutics, Rare Disease Treatment Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Dynacure: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Dynacure on 29 May 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.